Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Lyka Labs LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:500259NSE Symbol: LYKALABSP/E(TTM):420.71
ISIN Demat:INE933A01014Div & Yield %:0EPS(TTM):0.35
Book Value(Rs):35.452956Market Cap ( Cr.):525.54Face Value(Rs):10
    Change Company 
Managing Director & CEOKUNAL NARENDRA GANDHI
Executive Director & CFOYogesh B Shah
Non-Exec. & Independent Dir.Dhara P. Shah
Company Sec. & Compli. OfficerKishore P Shah
Chairman & Independent DirectoBabulal Jain
Non Executive DirectorPrashant Godha
Shashil Mendonsa